ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Myogen

Myogen (MYOG)

0.00
0.00
(0.00%)
At close: September 24 4:00PM
0.00
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MYOG Latest News

Gilead Sciences Completes Acquisition of Myogen

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has completed its acquisition of Myogen, Inc. (Nasdaq:MYOG). On November 17, 2006, Gilead caused one of its...

Darusentan Data to Be Presented at AHA 2006 -- Chicago

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG

CHICAGO, Oct. 2 /PRNewswire/ -- Seven Summits Research Releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at...

Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion

Gilead Sciences, Inc. (Nasdaq:GILD) and Myogen, Inc. (Nasdaq:MYOG) announced today that the companies have signed a definitive agreement under which Gilead plans to acquire...

Myogen to Present at the UBS Global Life Sciences Conference

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELYMEliem Therapeutics Inc
$ 9.77
(48.93%)
1.28M
VSMEVS Media Holdings Ltd
$ 1.69
(37.40%)
925.17k
MSGMMotorsport Games Inc
$ 1.45
(31.82%)
2.71M
FEAM5E Advanced Materials Inc
$ 0.5045
(23.53%)
2.08k
XHGXChange TED Inc
$ 1.46
(21.67%)
3.24M
VTNRVertex Energy Inc
$ 0.1811
(-49.83%)
358.32k
SFIXStitch Fix Inc
$ 2.84
(-24.27%)
1.34M
ATXSAstria Therapeutics Inc
$ 10.85
(-13.20%)
51.74k
BNZIBanzai International Inc
$ 7.2099
(-12.50%)
713.44k
TRNRInteractive Strength Inc
$ 0.23
(-12.21%)
1.59M
INTCIntel Corporation
$ 22.84
(0.13%)
17.5M
NVDANVIDIA Corporation
$ 121.78
(0.75%)
15.67M
ELABElevai Labs Inc
$ 0.12
(16.50%)
13.91M
JGLOJP Morgan Global Select Equity ETF
$ 62.28
(0.00%)
13.85M
LIPOLipella Pharmaceuticals Inc
$ 0.5131
(13.24%)
6.61M

Your Recent History

Delayed Upgrade Clock